PHARMACY

IGPA calls for TPP focus on generics

BY David Salazar

WASHINGTON — The International Generic Pharmaceutical Alliance has issued a statement calling on parties negotiating the Trans-Pacific Partnership to make access to affordable medication a priority.

According to IGPA, TPP, which is being negotiated by 12 countries including the U.S., in its current state “protects the interests of brand medicine manufacturers at the expense of public health.”

“IGPA supports trade agreements which promote the distribution of safe and affordable medicines and contribute to the sustainability of healthcare systems globally,” IGPA said. “Unfortunately, based on available information, TPP will threaten the right of “access to medicines for all” enshrined in the 2001 WTO Doha Declaration and recognized by all 12 TPP countries.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Access barrier created by distinguishable names for biosimilars, GPhA says

BY Michael Johnsen

WASHINGTON — The Biosimilars Council, a division of the Generic Pharmaceutical Association, on Tuesday strongly urged the Department of Health and Human Services and the Food and Drug Administration to avoid any departure from the currently accepted international nonproprietary naming system. In a letter sent today to HHS and FDA, the Biosimilars Council joined a group of healthcare stakeholders to raise shared concerns that adopting distinguishable names for biosimilars and biologics would erect barriers to patient access to new, more affordable medicines and could jeopardize their safety.
 
“Organizations representing the nation’s pharmacies, pharmacists, insurers, state employee retirement systems, taxpayers and others agree that biologics and biosimilars should share the same name in order to ensure patient safety and avoid confusion among providers and dispensers,” stated Ralph Neas, president and CEO, GPhA.
 
“We share the FDA's deep commitment to patient safety, and as such, we believe that biologics and biosimilars should be required to have the same International Nonproprietary Name," the Council submitted in its letter. "Requiring different INNs for biologics and biosimilars could lead to patient and prescriber confusion, increasing the possibility of medication errors, and would also effectively separate the biosimilar from existing safety information about the underlying molecule.”
 
The Council suggested that the current mechanisms in place (e.g., NDC code, lot number, brand name, manufacturer, etc.) are more than sufficient to allow for the tracking of important safety information related to new biosimilar products. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Seasoned Target vet joins Rite Aid as EVP operations

BY Michael Johnsen

CAMP HILL, Pa. – Rite Aid on Monday announced that Bryan Everett is joining Rite Aid as EVP store operations, effective Aug. 3. In this position, Everett will be responsible for all operations at the company’s nearly 4,600 chainwide stores and will report to Rite Aid’s president and COO Ken Martindale.
 
Everett will succeed Bob Thompson, who has announced his retirement from the company, effective January 2016.
 
“Bryan is an energetic and talented leader with a proven track record of operational expertise and success,” said Martindale. “We are pleased to welcome Bryan to Rite Aid and are confident Rite Aid will benefit from his outstanding leadership skills as we work together to continue to successfully grow our business and achieve long-term success," he said. “I would also like to acknowledge the many valuable contributions Bob Thompson has made to Rite Aid since joining our company over seven years ago. He has been a key member of our management team that, along with our nearly 90,000 associates, has executed a successful turnaround and positioned Rite Aid for long-term growth. We appreciate his leadership and commitment to Rite Aid during this important time.”
 
Thompson will continue reporting to Martindale until his retirement, working on specified service initiatives designed to continue to improve the overall customer experience in Rite Aid stores as well as assisting in the leadership transition.
 
Everett comes to Rite Aid with 20 years of experience in store operations. He joined Target Corporation in 2002, where he held various store operations positions of increasing responsibility. He most recently served as SVP store operations for the company. In this role, he focused on talent management, operational efficiency and integrated technology solutions. He also led new format, new store and remodeling programs while also overseeing pharmacy and clinic operations.
 
Before joining Target, Everett also held store operations management positions at Fleming Wholesale and ALDI.
 
Everett earned his bachelor’s degree in corporate communications from Western Kentucky University in Bowling Green, Ky., and a master’s degree in human resource development from Indiana State University from Terre Haute, Ind.
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?